Delivery Order SPE2DB22D1103-SPE2DB25FTNP3
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.03, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,434.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,939.82, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is for the delivery of a specific pharmaceutical product, ADBRY 300 MG/2 ML AUTOINJECTOR 2ML. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This federal contract award, valued at $5,716.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a completion date of February 19, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is a delivery order for the medical product "ADBRY 300 MG/2 ML AUTOINJECTOR 2ML". The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, and has a ceiling value of $3,415.71. The contract is a delivery order, with a firm fixed price pricing type. It has an ultimate completion date of May 21, 2025 and was awarded on May 20, 2025. The place of performance is...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of an autoinjector product (ADBRY 300 MG/2 ML AUTOINJECTOR 2ML) with a ceiling value of $19,912.70 and a period of performance through February 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,083.54 firm fixed-price contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical supply. The contract has an ultimate completion date of May 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $7,275.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, for the provision of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical supplies. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...